HK1159102A1 - Inhibitors of ssao activity ssao - Google Patents

Inhibitors of ssao activity ssao

Info

Publication number
HK1159102A1
HK1159102A1 HK11113628.0A HK11113628A HK1159102A1 HK 1159102 A1 HK1159102 A1 HK 1159102A1 HK 11113628 A HK11113628 A HK 11113628A HK 1159102 A1 HK1159102 A1 HK 1159102A1
Authority
HK
Hong Kong
Prior art keywords
ssao
inhibitors
activity
ssao activity
activity ssao
Prior art date
Application number
HK11113628.0A
Other languages
English (en)
Chinese (zh)
Inventor
．薩沃里
．希金博特姆
．奧利弗
．霍根
Original Assignee
普羅克西梅根有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 普羅克西梅根有限公司 filed Critical 普羅克西梅根有限公司
Publication of HK1159102A1 publication Critical patent/HK1159102A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Rheumatology (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Transplantation (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK11113628.0A 2008-09-16 2011-12-16 Inhibitors of ssao activity ssao HK1159102A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0801979 2008-09-16
US10673408P 2008-10-20 2008-10-20
PCT/EP2009/062011 WO2010031789A1 (fr) 2008-09-16 2009-09-16 Composés inédits i

Publications (1)

Publication Number Publication Date
HK1159102A1 true HK1159102A1 (en) 2012-07-27

Family

ID=41226693

Family Applications (1)

Application Number Title Priority Date Filing Date
HK11113628.0A HK1159102A1 (en) 2008-09-16 2011-12-16 Inhibitors of ssao activity ssao

Country Status (16)

Country Link
US (7) US8263616B2 (fr)
EP (1) EP2334672B1 (fr)
JP (1) JP5539989B2 (fr)
CN (1) CN102232073B (fr)
AU (1) AU2009294660B2 (fr)
BR (1) BRPI0918602B8 (fr)
CA (1) CA2737527C (fr)
DK (1) DK2334672T3 (fr)
EA (1) EA019167B1 (fr)
ES (1) ES2440279T3 (fr)
HK (1) HK1159102A1 (fr)
MX (1) MX2011002581A (fr)
NZ (1) NZ592238A (fr)
PL (1) PL2334672T3 (fr)
PT (1) PT2334672E (fr)
WO (1) WO2010031789A1 (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA019167B1 (ru) 2008-09-16 2014-01-30 Проксимаген Лимитед Соединения, ингибирующие активность семикарбазид-чувствительной аминооксидазы
UA112154C2 (uk) * 2009-09-08 2016-08-10 Біоті Терапіс Корп. Застосування повністю людського анти-vap-1-антитіла для лікування фіброзних станів
GB201004311D0 (en) 2010-03-15 2010-04-28 Proximagen Ltd New enzyme inhibitor compounds
CN102311396B (zh) * 2010-07-05 2015-01-07 暨南大学 一种吡嗪类衍生物和其制备方法及在制药中的应用
FI20115234A0 (fi) 2011-03-08 2011-03-08 Biotie Therapies Corp Uusia pyridatsinoni- ja pyridoniyhdisteitä
SG11201400277VA (en) 2011-09-14 2014-05-29 Proximagen Ltd New enzyme inhibitor compounds
GB201304526D0 (en) * 2013-03-13 2013-04-24 Proximagen Ltd New compounds
GB201304527D0 (en) 2013-03-13 2013-04-24 Proximagen Ltd New compounds
AU2014279863A1 (en) 2013-06-12 2016-01-28 Proximagen Limited New therapeutic uses of enzyme inhibitors
WO2015189534A1 (fr) 2014-06-12 2015-12-17 Proximagen Limited Inhibiteurs de vap-1 pour le traitement de la dystrophie musculaire
GB201416446D0 (en) * 2014-09-17 2014-10-29 Proximagen Ltd New enzyme inhibitor compounds
GB201416444D0 (en) 2014-09-17 2014-10-29 Proximagen Ltd New compounds
KR102137350B1 (ko) 2015-03-02 2020-07-23 닛본 덴끼 가부시끼가이샤 디코딩 장치, 수신기기, 송신기기, 송수신 시스템, 디코딩 방법, 및 디코딩 프로그램이 저장된 저장매체
GB201507031D0 (en) * 2015-04-24 2015-06-10 Proximagen Ltd New pharmaceutical salt forms
GB201507048D0 (en) 2015-04-24 2015-06-10 Proximagen Ltd Treatment of pain
GB201507036D0 (en) * 2015-04-24 2015-06-10 Proximagen Ltd Crystalline enzyme inhibitor compound
GB201513115D0 (en) 2015-07-24 2015-09-09 Proximagen Ltd New therapeutic compound and use in therapy
CA3005353A1 (fr) 2015-11-20 2017-05-26 Forma Therapeutics, Inc. Purinones utilises comme inhibiteurs de la protease specifique de l'ubiquitine 1
JP2019502672A (ja) * 2015-12-07 2019-01-31 ベネボレンタイ ケンブリッジ リミティド 疼痛の治療のためのｖａｐ−１阻害剤
GB201618029D0 (en) 2016-10-25 2016-12-07 Proximagen Ltd New process
EP3902802A4 (fr) * 2018-12-28 2022-09-07 Forma Therapeutics, Inc. Compositions pour inhiber la protéase 1 spécifique de l'ubiquitine

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4141899A (en) * 1976-01-07 1979-02-27 Societa' Farmaceutici Italia S.P.A. 4,5,6,7-Tetrahydroimidazo-[4,5-c]-pyridine derivatives
JPS5285191A (en) * 1976-01-07 1977-07-15 Farmaceutici Italia Novel 4*5*6*77tetrahydroimidazoo *4*55c*pyridine derivative process for preparing same and medicine having antiiulcer antiisecretion and antiicolline activities containing same
IT1098015B (it) * 1978-08-07 1985-08-31 Farmaceutici Italia Nuovi 4,5,6,7,-tetraidroimidazo-aperta par.quadrata 4,5-c chiusa par.quadrata-piridin-derivati
US6908926B1 (en) 1999-04-16 2005-06-21 Novo Nordisk A/S Substituted imidazoles, their preparation and use
WO2002038153A1 (fr) * 2000-11-09 2002-05-16 Biovitrum Ab Nouvelle utilisation de derives de 4, 5, 6, 7-tetrahydroimidazo-[4,5-c]pyridine
SE0004101D0 (sv) * 2000-11-09 2000-11-09 Pharmacia Ab New use
US6576249B1 (en) * 2000-11-13 2003-06-10 El Gendler Bone putty and method
EA019167B1 (ru) 2008-09-16 2014-01-30 Проксимаген Лимитед Соединения, ингибирующие активность семикарбазид-чувствительной аминооксидазы

Also Published As

Publication number Publication date
AU2009294660A1 (en) 2010-03-25
BRPI0918602A2 (pt) 2015-12-15
EA019167B1 (ru) 2014-01-30
US10399973B2 (en) 2019-09-03
US20120302583A1 (en) 2012-11-29
US20150218161A1 (en) 2015-08-06
JP5539989B2 (ja) 2014-07-02
CN102232073B (zh) 2014-10-29
US11040969B2 (en) 2021-06-22
US9493457B2 (en) 2016-11-15
WO2010031789A1 (fr) 2010-03-25
AU2009294660B2 (en) 2013-11-14
BRPI0918602B1 (pt) 2020-04-07
PL2334672T3 (pl) 2014-03-31
CA2737527A1 (fr) 2010-03-25
CA2737527C (fr) 2015-12-29
US8263616B2 (en) 2012-09-11
US9035066B2 (en) 2015-05-19
EP2334672B1 (fr) 2013-11-20
US20110207746A1 (en) 2011-08-25
CN102232073A (zh) 2011-11-02
BRPI0918602B8 (pt) 2021-05-25
PT2334672E (pt) 2014-01-02
MX2011002581A (es) 2011-04-07
US20180118744A1 (en) 2018-05-03
JP2012506368A (ja) 2012-03-15
US20170044157A1 (en) 2017-02-16
EA201100391A1 (ru) 2011-10-31
US20190359611A1 (en) 2019-11-28
EP2334672A1 (fr) 2011-06-22
US9890160B2 (en) 2018-02-13
ES2440279T3 (es) 2014-01-28
NZ592238A (en) 2012-11-30
DK2334672T3 (da) 2013-12-02
US20140121219A1 (en) 2014-05-01
US8569338B2 (en) 2013-10-29

Similar Documents

Publication Publication Date Title
HK1159102A1 (en) Inhibitors of ssao activity ssao
EP2303269A4 (fr) Inhibiteurs de l'activité akt
EP2391623A4 (fr) Inhibiteurs de l'activité d'akt
HK1132676A1 (en) Inhibitors of akt activity akt
EP2413932A4 (fr) Inhibiteurs de l'activité akt
EP2406250A4 (fr) Inhibiteurs de l'activité akt
HK1172896A1 (zh) 化合物和使用方法
HK1161094A1 (en) Compounds and methods of use
IL209488A0 (en) Inhibitors of akt activity
EP2114388A4 (fr) Inhibiteurs de l'activité de akt
HK1171390A1 (en) Heparanase activity inhibitor
EP2303852A4 (fr) Inhibiteurs d activité akt
EP2306825A4 (fr) Inhibiteurs de l'activité de l'akt
EP2405756A4 (fr) Inhibiteurs de l'activité akt
EP2134175A4 (fr) Inhibiteurs de l'activité de akt
HK1171013A1 (en) Inhibitors of akt activity akt
EP2120951A4 (fr) Inhibiteurs de l'activité akt
HK1160925A1 (zh) 組織蛋白酶 的用途
EP2303277A4 (fr) Inhibiteurs de l'activité de l'akt
EP2579872A4 (fr) Inhibiteurs de l'activité akt
EP2303017A4 (fr) Inhibiteurs d activité akt
EP2303258A4 (fr) Inhibiteurs d activité akt
SI2411376T1 (sl) INHIBITORJI NF-kB
EP2513059A4 (fr) Inhibiteurs de l'activité akt
GB2452842B (en) Method of increasing activity

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20220914